Synthetic blood: a future alternative.
D000818:Animals; D001802:Blood Substitutes; D002614:Chelating Agents / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D005466:Fluorocarbons / Q000009:adverse effects / Q000627:therapeutic use; D006454:Hemoglobins; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives; D008297:Male; D051379:Mice; D009732:Nursing Care
D001802:Blood Substitutes; D002614:Chelating Agents; D004338:Drug Combinations; D005466:Fluorocarbons; D006454:Hemoglobins; D006895:Hydroxyethyl Starch Derivatives; C017323:glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination